In the Policy Forum “Was there ever really a ‘sugar conspiracy’?” (16 February, p. 747), D. M. Johns and G. M. Oppenheimer based their criticism of our research on news stories, press releases, a podcast, and a commentary, not our peer-reviewed papers (1, 2). Contrary to their assertions, our publications do indeed “focus on the evidence” and “follow the data.”
Our JAMA Internal Medicine paper (1) demonstrated that Harvard nutrition researchers McGandy, Hegsted, and Stare used a double standard when critiquing the epidemiologic, experimental, and mechanistic evidence linking sugar to heart disease in their Sugar Research Foundation (SRF)–funded 1967 New England Journal of Medicine review (3, 4). Hegsted’s beliefs and publications that were unfavorable to his meat and dairy industry sponsors have no bearing on our conclusions about the bias in his review on the health effects of sugar. Johns and Oppenheimer attempt to put the research in the context of the time, but “logic and tools” and “norms and standards” have always called upon scientists to apply objective criteria when evaluating evidence.
We did not conclude that McGandy et al.’s review “meaningfully shaped the course of dietary science and policy,” as asserted by Johns and Oppenheimer. Rather, we concluded that the sugar industry’s sponsorship of this review, together with other historical and current evidence (5–8), suggests that the industry may have a long history of influence. Our recent PLOS Biology paper (2) further documented how SRF terminated funding for and failed to disclose or follow up on preliminary data in the 1970s that strengthened the emerging case—borne out by subsequent research (9)—that elevated triglycerides are a cardiometabolic risk factor and that sugar raises triglycerides.
Efforts to understand the impact of SRF’s research program, which dates to 1943 (10), are hardly “ahistorical,” a “conspiratorial narrative,” or a “fallacy of emphasizing the machinations of one commodity sector.” Rather, they are a necessary step to providing critical context about these industries, which is currently missing from historical accounts and policy discussions.
REFERENCES
- 1.Kearns CE, Schmidt LA, Glantz SA, JAMA Intern. Med 176, 1680 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kearns CE, Apollonio D, Glantz SA, PLOS Biol. 15, e2003460 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McGandy RB, Hegsted DM, Stare FJ, New Engl. J. Med 277, 186 (1967). [DOI] [PubMed] [Google Scholar]
- 4.McGandy RB, Hegsted DM, Stare FJ, New Engl. J. Med 277, 242 (1967). [DOI] [PubMed] [Google Scholar]
- 5.Kearns CE, Glantz SA, Schmidt LA, PLOS Med. 12, e1001798 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Taubes G, Couzens CK, “Big sugar’s sweet little lies: How the industry kept scientists from asking, does sugar kill?,” Mother Jones (Nov-Dec, 2012). [Google Scholar]
- 7.The Sugar Association, “Sugar and heart health: What are the facts?” (2015); www.sugar.org/sugar-heart-health-facts/.
- 8.Office of Disease Prevention and Health Promotion, “Sugar Association comment ID #22978 submitted 05/07/2015” (2015); https://health.gov/dietaryguide-lines/dga2015/comments/readCommentDetails.aspx?CID=22978. [Google Scholar]
- 9.Dietary Guidelines Advisory Committee, “Scientific report of the 2015 Dietary Guidelines Advisory Committee” (U.S. Department of Health and Human Services and U.S. Department of Agriculture, Washington, DC, 2015). [Google Scholar]
- 10.Cheek DW, Sugar Research, 1943–1972 (International Sugar Research Foundation, 1974). [Google Scholar]
